221 related articles for article (PubMed ID: 1437342)
21. A multicenter randomized, masked comparison trial of natural versus synthetic surfactant for the treatment of respiratory distress syndrome.
Hudak ML; Farrell EE; Rosenberg AA; Jung AL; Auten RL; Durand DJ; Horgan MJ; Buckwald S; Belcastro MR; Donohue PK; Carrion V; Maniscalco WW; Balsan MJ; Torres BA; Miller RR; Jansen RD; Graeber JE; Laskay KM; Matteson EJ; Egan EA; Brody AS; Martin DJ; Riddlesberger MM; Montgomery P
J Pediatr; 1996 Mar; 128(3):396-406. PubMed ID: 8774514
[TBL] [Abstract][Full Text] [Related]
22. Nasal intermittent positive pressure ventilation after surfactant treatment for respiratory distress syndrome in preterm infants <30 weeks' gestation: a randomized, controlled trial.
Ramanathan R; Sekar KC; Rasmussen M; Bhatia J; Soll RF
J Perinatol; 2012 May; 32(5):336-43. PubMed ID: 22301528
[TBL] [Abstract][Full Text] [Related]
23. Multicenter controlled clinical trial of high-frequency jet ventilation in preterm infants with uncomplicated respiratory distress syndrome.
Keszler M; Modanlou HD; Brudno DS; Clark FI; Cohen RS; Ryan RM; Kaneta MK; Davis JM
Pediatrics; 1997 Oct; 100(4):593-9. PubMed ID: 9310511
[TBL] [Abstract][Full Text] [Related]
24. Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia.
Bassler D
Neonatology; 2015; 107(4):358-9. PubMed ID: 26044104
[TBL] [Abstract][Full Text] [Related]
25. Pulmonary Surfactant Replacement Therapy for Respiratory Distress Syndrome in Neonates: a Nationwide Epidemiological Study in Korea.
Shin JE; Yoon SJ; Lim J; Han J; Eun HS; Park MS; Park KI; Lee SM
J Korean Med Sci; 2020 Aug; 35(32):e253. PubMed ID: 32808509
[TBL] [Abstract][Full Text] [Related]
26. Increased ADMA levels are associated with poor pulmonary outcome in preterm neonates.
Kavurt S; Demirel N; Bas AY; Ulubas Isık D; Ozcan B; Aydemir O
J Matern Fetal Neonatal Med; 2017 Apr; 30(7):864-869. PubMed ID: 27268203
[TBL] [Abstract][Full Text] [Related]
27. Early respiratory management of respiratory distress syndrome in very preterm infants and bronchopulmonary dysplasia: a case-control study.
Te Pas AB; Lopriore E; Engbers MJ; Walther FJ
PLoS One; 2007 Feb; 2(2):e192. PubMed ID: 17285145
[TBL] [Abstract][Full Text] [Related]
28. The short-term outcome of a large cohort of very preterm infants treated with poractant alfa (Curosurf) for respiratory distress syndrome. A postmarketing phase IV study.
Lamboley-Gilmert G; Lacaze-Masmonteil T;
Paediatr Drugs; 2003; 5(9):639-45. PubMed ID: 12956620
[TBL] [Abstract][Full Text] [Related]
29. [Efficacy analysis of different pulmonary surfactants in premature infants with respiratory distress syndrome].
Xu H; Xu P
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Feb; 33(2):174-179. PubMed ID: 33729136
[TBL] [Abstract][Full Text] [Related]
30. Late Surfactant Administration in Very Preterm Neonates With Prolonged Respiratory Distress and Pulmonary Outcome at 1 Year of Age: A Randomized Clinical Trial.
Hascoët JM; Picaud JC; Ligi I; Blanc T; Moreau F; Pinturier MF; Zupan V; Guilhoto I; Hamon IR; Alexandre C; Bouissou A; Storme L; Patkai J; Pomedio M; Rouabah M; Coletto L; Vieux R
JAMA Pediatr; 2016 Apr; 170(4):365-72. PubMed ID: 26928567
[TBL] [Abstract][Full Text] [Related]
31. A randomized pilot study comparing heated humidified high-flow nasal cannulae with NIPPV for RDS.
Kugelman A; Riskin A; Said W; Shoris I; Mor F; Bader D
Pediatr Pulmonol; 2015 Jun; 50(6):576-83. PubMed ID: 24619945
[TBL] [Abstract][Full Text] [Related]
32. [Epidemiological survey of neonatal respiratory distress syndrome in part of northwest regions in China].
Network of Northwest Neonatal Professional Collaboration Group
Zhonghua Er Ke Za Zhi; 2015 May; 53(5):341-7. PubMed ID: 26080663
[TBL] [Abstract][Full Text] [Related]
33. Multicenter trial of single-dose modified bovine surfactant extract (Survanta) for prevention of respiratory distress syndrome. Ross Collaborative Surfactant Prevention Study Group.
Soll RF; Hoekstra RE; Fangman JJ; Corbet AJ; Adams JM; James LS; Schulze K; Oh W; Roberts JD; Dorst JP
Pediatrics; 1990 Jun; 85(6):1092-102. PubMed ID: 2187176
[TBL] [Abstract][Full Text] [Related]
34. Patent ductus arteriosus hemodynamics in very premature infants treated with poractant alfa or beractant for respiratory distress syndrome.
Fujii A; Allen R; Doros G; O'Brien S
J Perinatol; 2010 Oct; 30(10):671-6. PubMed ID: 20336077
[TBL] [Abstract][Full Text] [Related]
35. The effect of early dexamethasone administration on bronchopulmonary dysplasia in preterm infants with respiratory distress syndrome.
Tapia JL; Ramírez R; Cifuentes J; Fabres J; Hübner ME; Bancalari A; Mercado ME; Standen J; Escobar M
J Pediatr; 1998 Jan; 132(1):48-52. PubMed ID: 9469999
[TBL] [Abstract][Full Text] [Related]
36. [Prevention and treatment of respiratory distress syndrome in premature infants using intratracheally administered surfactants].
de Winter JP; Egberts J; de Kleine MJ; van Bel F; Wijnands JB; Guit GL
Ned Tijdschr Geneeskd; 1992 Oct; 136(41):2018-24. PubMed ID: 1407193
[TBL] [Abstract][Full Text] [Related]
37. Double-blind, randomized, placebo-controlled Canadian multicenter trial of two doses of synthetic surfactant or air placebo in 224 infants weighing 500 to 749 grams with respiratory distress syndrome. Canadian Exosurf Neonatal Study Group.
Smyth J; Allen A; MacMurray B; Peliowski A; Sankaran K; Volberg F; Shukla A; Long W
J Pediatr; 1995 May; 126(5 Pt 2):S81-9. PubMed ID: 7745516
[TBL] [Abstract][Full Text] [Related]
38. High-dose versus low-dose bovine surfactant treatment in very premature infants.
Gortner L; Pohlandt F; Bartmann P; Bernsau U; Porz F; Hellwege HH; Seitz RC; Hieronimi G; Kuhls E; Jorch G
Acta Paediatr; 1994 Feb; 83(2):135-41. PubMed ID: 8193488
[TBL] [Abstract][Full Text] [Related]
39. Animal derived surfactant extract for treatment of respiratory distress syndrome.
Seger N; Soll R
Cochrane Database Syst Rev; 2009 Apr; (2):CD007836. PubMed ID: 19370695
[TBL] [Abstract][Full Text] [Related]
40. Effects of two rescue doses of a synthetic surfactant on mortality rate and survival without bronchopulmonary dysplasia in 700- to 1350-gram infants with respiratory distress syndrome. The American Exosurf Neonatal Study Group I.
Long W; Thompson T; Sundell H; Schumacher R; Volberg F; Guthrie R
J Pediatr; 1991 Apr; 118(4 Pt 1):595-605. PubMed ID: 2007938
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
